- Home
- ATYR vs CZNC Comparison
ATYR vs CZNC Comparison
Compare ATYR & CZNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- CZNC
- Stock Information
- Founded
- ATYR 2005
- CZNC 1864
- Country
- ATYR United States
- CZNC United States
- Employees
- ATYR N/A
- CZNC N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- CZNC Major Banks
- Sector
- ATYR Health Care
- CZNC Finance
- Exchange
- ATYR Nasdaq
- CZNC Nasdaq
- Market Cap
- ATYR 290.6M
- CZNC 286.0M
- IPO Year
- ATYR 2015
- CZNC N/A
- Fundamental
- Price
- ATYR $3.34
- CZNC $19.13
- Analyst Decision
- ATYR Strong Buy
- CZNC
- Analyst Count
- ATYR 6
- CZNC 0
- Target Price
- ATYR $18.60
- CZNC N/A
- AVG Volume (30 Days)
- ATYR 1.1M
- CZNC 35.9K
- Earning Date
- ATYR 05-07-2025
- CZNC 04-23-2025
- Dividend Yield
- ATYR N/A
- CZNC 5.85%
- EPS Growth
- ATYR N/A
- CZNC 15.34
- EPS
- ATYR N/A
- CZNC 1.75
- Revenue
- ATYR N/A
- CZNC $108,114,000.00
- Revenue This Year
- ATYR $551.06
- CZNC $9.38
- Revenue Next Year
- ATYR $2,144.84
- CZNC $3.77
- P/E Ratio
- ATYR N/A
- CZNC $10.96
- Revenue Growth
- ATYR N/A
- CZNC 5.33
- 52 Week Low
- ATYR $1.42
- CZNC $16.50
- 52 Week High
- ATYR $4.66
- CZNC $22.68
- Technical
- Relative Strength Index (RSI)
- ATYR 51.21
- CZNC 51.97
- Support Level
- ATYR $3.06
- CZNC $18.75
- Resistance Level
- ATYR $3.67
- CZNC $19.50
- Average True Range (ATR)
- ATYR 0.25
- CZNC 0.54
- MACD
- ATYR 0.01
- CZNC 0.08
- Stochastic Oscillator
- ATYR 46.77
- CZNC 56.36
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.